Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case
Vallacchi V, et al.
Journal for ImmunoTherapy of Cancer
January 2024
Authors and Affiliates
Viviana Vallacchi 1, Elisabetta Vergani 1, Mara Cossa 2, Chiara Gargiuli 3, Adele Busico 4, Andrea Devecchi 4, Matteo Dugo 5, Laura Bergamaschi 1, Loris De Cecco 6, Stefano Cavalieri 7,8, Barbara Valeri 2, Elena Tamborini 4, Gianfrancesco Gallino 9, Michele Del Vecchio 7, Mario Santinami 9, Marialuisa Sensi 3, Licia Rivoltini 1, Lorenza Di Guardo 7, Monica Rodolfo 10;
1 Department of Experimental Oncology, Unit of Translational Immunology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
2 Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
3 Applied Research and Technology Development Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
4 Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
5 Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.
6 Integrated Biology of Rare Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
7 Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
8 Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
9 Melanoma Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
10 Department of Experimental Oncology, Unit of Translational Immunology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy monica.rodolfo@istitutotumori.mi.it.